Saladax Biomedical is a personalized medicine diagnostics company that is successfully pioneering the development and commercialization of innovative patented immunoassays to simply and accurately measure chemotherapy blood levels. This will enable oncologists to precisely adjust and personalize the chemotherapy dosage administered to achieve optimal systemic target blood levels. As a result, Personalized Chemotherapy Management (PCM®) will provide oncologists with a new tool to balance efficacy against side effects, thereby reducing toxicity, improving outcomes, and lowering cancer care costs.
What Is Personalized Medicine & How Does It Relate to Optimal Dose Management?
"Personalized medicine" refers to the tailoring of medical treatment to the individual characteristics of each patient. It does not literally mean the creation of drugs or medical devices that are unique to a patient but rather the ability to classify individuals into subpopulations that differ in their susceptibility to a particular disease or their response to a specific treatment. Preventive or therapeutic interventions can then be concentrated on those who will benefit, sparing expense and side effects for those who will not."
The article goes on to point out that one of the goals of personalized medicine is to "Determine optimal dosages for drugs whose therapeutic effect is known to vary widely."
President's Council of Advisors on Science and Technology (PCAST) "Priorities for Personalized Medicine", September 2008.
(Entire Article Available at: http://www.ostp.gov/galleries/PCAST/pcast_report_v2.pdf